Tracheal airway pressure in tracheostomy tube capping trials: an experimental study.
Andreas Nowak, Sten Martin, Maik Höhne...
https://pubmed.ncbi.nlm.nih.gov/36539764/Actively Recruiting
Led by Pontificia Universidad Catolica de Chile · Updated on 2026-09-09
22
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate two methods used to determine if critically ill patients with tracheostomy tubes are ready to breathe normally without assistance. The study focuses on patients who require long-term mechanical ventilation and need their tracheostomy tube removed safely. The goal is to compare the standard capping trial, where the tube is blocked to force breathing through the upper airway, with a new approach that adds extra tubing to better mimic breathing conditions after tube removal. Participants will undergo both the incremental instrumental dead space trial and the traditional capping trial in random order during a single study day. Each trial lasts 45 minutes, separated by a 20-minute rest period breathing through an open tube connected to the tracheostomy. After completing both trials and clinical confirmation, participants will be assessed again after the actual removal of the tracheostomy tube. During the study, researchers will measure breathing effort, muscle activity, and comfort. They will use specific physiological markers such as the pressure-time product and muscle electromyography to compare trial results with actual breathing after tube removal. The study will also monitor breathing discomfort and esophageal pressure changes to determine which method better predicts true respiratory status. Participation includes all assessments on the study day, and results will guide future approaches to tracheostomy decannulation.
CONDITIONS
Incremental Dead Space Versus Capping Trial Before Tracheostomy Decannulation
R
Roque Basoalto Escobar, MSc, PhD
E
Eduardo Kattan Tala, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Pontificia Universidad Catolica de Chile
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants undergo both the incremental dead space trial and the capping trial in random order on a single study day, with each trial lasting 45 minutes and separated by a 20-minute rest period. After completing both trials and clinical confirmation, participants have a post-decannulation assessment.
3 visits (two trial periods and one post-decannulation assessment)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Andreas Nowak, Sten Martin, Maik Höhne...
https://pubmed.ncbi.nlm.nih.gov/36539764/Candice J Devlin, Rory S O'Bryan, Hope Williams...
https://pubmed.ncbi.nlm.nih.gov/39532496/Roque Basoalto, Yorschua Jalil, Javiera Guzman...
https://pubmed.ncbi.nlm.nih.gov/41775545/Pontificia Universidad Catolica de Chile
Lead Sponsor